Вход на сайт

Просмотр новости

Найдите то, что Вас интересует

Surgical Outcomes of Perioperative Toripalimab in Stage III Resectable Non–Small Cell Lung Cancer

Дата публикации: 01-09-2026 00:00:00

This study evaluates perioperative toripalimab in combination with chemotherapy on surgical outcomes.

Схожие новости

#Наименование новостиТональностьИнформативностьДата публикации
1Perioperative Toripalimab in Stage III Non–Small Cell Lung Cancer014.3501-09-2026
2FLOT vs CROSS in Esophageal Adenocarcinoma06.0501-09-2026
3MAIBE for Patients With Locally Advanced Pancreatic Cancer05.9201-09-2026
4Q&A: Combining diagnosis, staging, tumor localization and surgery into a minimally invasive procedure for lung cancer06.902-09-2026
5Lumpectomy Margins and Local Recurrence in DCIS08.5501-09-2026
6Clinical trial to treat rectal cancer spares major surgery08.4924-08-2026
7Tumor response to immunochemotherapy may spare some head and neck cancer patients radical surgery07.2210-09-2026
8Recalibrating “Unresectable” in Pancreatic Cancer012.6201-09-2026
9Study identifies potential RAS inhibitor-immunotherapy strategy for pancreatic cancer07.4823-09-2026
10Augmented Reality Thoracic Surgery and the Patient Experience09.401-09-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 10. Тональность: 0. Информативность: 6.4. Источник: archderm.jamanetwork.com.